19 June 2013
Keywords: hoechst, amaryl, approved, diabetes, its, first, markets
Article | 02 October 1995
Hoechst has announced that its new oral antidiabetic drug Amaryl
(glimepiride) has now been approved in its first markets, the
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
2 October 1995
25 September 1995
9 October 1995
© 2013 thepharmaletter.com